SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-23-008279
Filing Date
2023-11-17
Accepted
2023-11-17 16:01:20
Documents
3
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A coeptis_def14a.htm DEF 14A 315159
2 GRAPHIC image_003.jpg GRAPHIC 5473
3 GRAPHIC image_004.jpg GRAPHIC 5480
  Complete submission text file 0001683168-23-008279.txt   331649
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39669 | Film No.: 231418488
SIC: 2836 Biological Products, (No Diagnostic Substances)